Teleflex Introduces Gibeck(R) Humid-Flo(R) Passive Humidification Kit

September 23, 2010
Kit Designed to Promote Best Practices for VAP Risk Reduction

LIMERICK, Pa., Sep 23, 2010 (BUSINESS WIRE) --

Teleflex has introduced the Gibeck Humid-Flo Passive Humidification Kit, an integrated system that promotes best practices for Ventilator Associated Pneumonia (VAP) risk reduction. This convenient kit includes everything required to initiate passive humidification for the first 72 hours of mechanical ventilation.

Multiple factors can cause Ventilator Associated Pneumonia, from environmental contaminants to harmful breaks in procedure.1 Verified for safety and performance, the Gibeck Humid-Flo Passive Humidification kit reduces the frequency of ventilator circuit breaks, allowing all components, including the heat & moisture exchanger (HME), to remain in-line during the first 72 hours of mechanical ventilation.

The innovative design of the Gibeck Humid-Flo HME allows it to remain in-line even when aerosol treatments are given. This allows clinicians to better adhere to clinical practice guidelines and recommendations from the CDC (Centers for Disease Control and Prevention), AARC (American Association for Respiratory Care) and SHEA (Society for Healthcare Epidemiology of America) regarding infection control practices for VAP, including:1,2,3

  • Do not routinely change more frequently than every 48 hours a heat-moisture exchanger that is in use by a patient.1
  • Passive humidifiers do not need to be changed daily for reasons of infection control or technical performance.2
  • Change an HME that is in use on a patient when it malfunctions mechanically or becomes visibly soiled. 3

"We are pleased to offer this novel approach to ventilation management that reduces the frequency of ventilator circuit breaks. Studies have shown that this reduces the risk for cross-contamination and VAP.4 This is yet another example of a solution that supports our mission to enhance patient outcomes by providing products and solutions that help clinicians protect against infections and improve patient and provider safety," said Cary Vance, Executive Vice President, Teleflex North America.

For more information on the Gibeck Humid-Flo Passive Humidification Kit, visit www.teleflexmedical.com.

About Teleflex Incorporated

Teleflex Incorporated (NYSE:TFX) is a global provider of medical technology products that enable healthcare providers to improve patient outcomes, reduce infections and support patient and provider safety. Teleflex, which employs approximately 12,600 people worldwide, also has niche businesses that serve segments of the aerospace and commercial markets with specialty engineered products. Additional information about Teleflex can be obtained from the company's website at www.teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

1 Coffin S MD, MPH, Klompas M MD, Classen D MD, et al. Strategies to Prevent Ventilator- Associated Pneumonia in Acute Care Hospitals. Infect Control Hosp Epidemiol 2008; 29:S31-S40.
2 AARC Evidence Based Guidelines, Care of the Ventilator Circuit and Its Relation to Ventilator Associated Pneumonia. Respiratory Care 2003;48:875.
3 Guidelines for Preventing Hospital Associated Pneumonia: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee 2003
4 Han J MD, PhD, Liu Y RRT. Effect of Ventilator Circuit Changes on Ventilator-Associated Pneumonia: A Systematic Review and Meta-analysis. Respiratory Care 2010; 55(4):471-472.

SOURCE: Teleflex Incorporated

Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836